Centessa Pharmaceuticals Company Insiders
CNTA Stock | USD 14.54 1.27 8.03% |
Centessa Pharmaceuticals' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Centessa Pharmaceuticals PLC suggests that vertually all insiders are panicking. Centessa Pharmaceuticals employs about 75 people. The company is managed by 20 executives with a total tenure of roughly 175 years, averaging almost 8.0 years of service per executive, having 3.75 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-03-20 | Saurabh Saha | Disposed 55000 @ 16.69 | View | ||
2025-03-17 | Iqbal J Hussain | Disposed 6000 @ 16.45 | View | ||
2025-02-20 | Saurabh Saha | Disposed 55000 @ 15.93 | View | ||
2025-02-18 | Iqbal J Hussain | Disposed 6000 @ 16.18 | View | ||
2025-02-10 | Karen M Anderson | Disposed 429 @ 18.99 | View | ||
2025-02-07 | Karen M Anderson | Disposed 30526 @ 19.03 | View | ||
2025-02-03 | Tia L Bush | Disposed 11000 @ 16.86 | View | ||
2025-01-27 | Gregory M Weinhoff | Disposed 11742 @ 16.47 | View | ||
2025-01-21 | Saurabh Saha | Disposed 55000 @ 15.77 | View | ||
2025-01-15 | Iqbal J Hussain | Disposed 6000 @ 15.29 | View | ||
2024-12-26 | Gregory M Weinhoff | Disposed 10000 @ 17.04 | View | ||
2024-12-20 | Saurabh Saha | Disposed 55000 @ 17.44 | View | ||
2024-12-17 | Tia L Bush | Disposed 17813 @ 18 | View | ||
2024-12-16 | Iqbal J Hussain | Disposed 77705 @ 16.39 | View | ||
2024-12-13 | Karen M Anderson | Disposed 5876 @ 17.01 | View | ||
2024-12-06 | Saurabh Saha | Disposed 87496 @ 18.46 | View | ||
2024-11-25 | Gregory M Weinhoff | Disposed 10000 @ 17.66 | View |
Monitoring Centessa Pharmaceuticals' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Centessa |
Centessa Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.2047) % which means that it has lost $0.2047 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4252) %, meaning that it created substantial loss on money invested by shareholders. Centessa Pharmaceuticals' management efficiency ratios could be used to measure how well Centessa Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 26, 2025, Return On Tangible Assets is expected to decline to -0.43. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Centessa Pharmaceuticals' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 6.5 M, whereas Total Assets are forecasted to decline to about 374.4 M.As of March 26, 2025, Common Stock Shares Outstanding is expected to decline to about 111.3 M. In addition to that, Net Loss is expected to decline to about (204.3 M)
Centessa Pharmaceuticals Workforce Comparison
Centessa Pharmaceuticals PLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,018. Centessa Pharmaceuticals holds roughly 75.0 in number of employees claiming about 2.49% of equities under Health Care industry.
Centessa Pharmaceuticals Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Centessa Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Centessa Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Centessa Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 0.4483 | 13 | 29 | 2,222,455 | 417,393 |
2024-12-01 | 0.3235 | 11 | 34 | 185,313 | 701,013 |
2024-09-01 | 0.2105 | 4 | 19 | 830,000 | 688,948 |
2024-06-01 | 1.2 | 6 | 5 | 288,000 | 72,329 |
2024-03-01 | 0.9412 | 16 | 17 | 1,803,500 | 243,196 |
2023-09-01 | 0.2222 | 2 | 9 | 37,484 | 152,031 |
2023-06-01 | 0.5 | 7 | 14 | 336,000 | 279,137 |
2023-03-01 | 1.6364 | 18 | 11 | 1,821,600 | 82,886 |
2022-12-01 | 0.0526 | 1 | 19 | 300,000 | 134,912 |
2022-09-01 | 0.5263 | 10 | 19 | 2,111,000 | 130,687 |
2022-06-01 | 4.5 | 9 | 2 | 676,000 | 29,422 |
2021-12-01 | 12.5 | 25 | 2 | 613,000 | 150,000 |
2021-06-01 | 1.2692 | 33 | 26 | 16,193,762 | 9,703,395 |
Centessa Pharmaceuticals Notable Stakeholders
A Centessa Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Centessa Pharmaceuticals often face trade-offs trying to please all of them. Centessa Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Centessa Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mario Accardi | President Program | Profile | |
MD MBA | Principal CFO | Profile | |
John CPA | CFO Officer | Profile | |
Tia Bush | Chief Officer | Profile | |
Ellie MD | Senior Oncology | Profile | |
MD MSc | Ex Devel | Profile | |
April Dovholuk | Senior Operations | Profile | |
JD Esq | Senior Communications | Profile | |
Charlene Stoudt | Senior Operations | Profile | |
MBA MD | Principal CFO | Profile | |
David Chao | Chief Officer | Profile | |
Thomas Templeman | Chief Officer | Profile | |
Joshua MBA | Sr Devel | Profile | |
David Grainger | Chief Officer | Profile | |
Saurabh MD | CEO Director | Profile | |
Patrick MD | Senior Medicines | Profile | |
Iqbal LLB | Chief Counsel | Profile | |
Harris Rotman | Senior Affairs | Profile | |
Karen Anderson | Chief Officer | Profile | |
MSc MD | Executive Development | Profile |
About Centessa Pharmaceuticals Management Performance
The success or failure of an entity such as Centessa Pharmaceuticals often depends on how effective the management is. Centessa Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Centessa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Centessa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.41) | (0.43) | |
Return On Capital Employed | (0.39) | (0.41) | |
Return On Assets | (0.41) | (0.43) | |
Return On Equity | (0.59) | (0.62) |
Please note, the presentation of Centessa Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Centessa Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Centessa Pharmaceuticals' management manipulating its earnings.
Centessa Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Centessa Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Centessa Pharmaceuticals within its industry.Centessa Pharmaceuticals Manpower Efficiency
Return on Centessa Pharmaceuticals Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 3.1M | |
Net Loss Per Executive | 11.8M | |
Working Capital Per Employee | 6.4M | |
Working Capital Per Executive | 23.9M |
Complementary Tools for Centessa Stock analysis
When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |